Dutch healthcare technology manufacturer Philips beat market expectations for third-quarter core earnings on Tuesday, driven by higher sales and gross margin alongside productivity measures.
Philips, which sells products ranging from toothbrushes to medical imaging systems, reported a 7.2% rise in its adjusted earnings before interest, taxes and amortisation to €569 million ($637 million), exceeding a consensus estimate of €522 million provided on the company’s website.
Philips also said its Respironics unit had reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations linked to its global sleep and respiratory-care device recall.
It booked a €288 million provision in the quarter for the proposed DOJ settlement, which remains subject to final documentation and is expected to be paid in the first quarter of 2027. The company did not provide details on whether the agreement would include an admission of wrongdoing.
“We cannot provide details qualitatively at this point in time,” CEO Roy Jakobs said in a call with journalists, adding the agreement in principle was reached “in the last few days”.
- Published On Nov 3, 2026 at 03:22 PM IST
Join the community of 2M+ industry professionals.
Subscribe to Newsletter to get latest insights & analysis in your inbox.
All about ETHealthworld industry right on your smartphone!
- Download the ETHealthworld App and get the Realtime updates and Save your favourite articles.
